
















Unlike pharmaceutical marketing in general, or manufacturing marketing, API marketing is unique because the people we market to are technically savvy, do searches at the molecular level and make their decisions based on regulatory filings and quality documentation, which most sites hide in PDFs. To get in touch with these kinds of buyers, you need a team that knows the pharmaceutical supply chain and knows how the actual purchasing decisions happen. This is rare.
Your Drug Master File and GMP filings prove all that a potential buyer wants to know about you - quality, regulatory status, production. However, if they live as static documents or internal files, they are invisible to search engines and AI systems and the buyers that are looking for something you produce find other companies instead.
When the API manufacturer’s website does not come up for molecule-level search terms such as ‘aceclofenac API supplier India’ or ‘metformin active pharmaceutical ingredient manufacturer’, buyers resort to B2B marketplaces. You end up losing out on the direct relationship, profit margins, and brand equity. It is easy to fix this problem once you understand the right way of structuring API sourcing searches. This is something that most digital marketing agencies do not know how to do.
Most API manufacturers cater to two types of buyers: the formulator buying a catalogue molecule and the company looking for custom API development. Each type searches differently, evaluates differently, and looks for different things. Putting them both on the same page is a surefire way of pleasing neither and having no presence in the relevant searches or AI answers.
Six services tailored explicitly for the API manufacturing industry sector, not an out-of-the-box manufacturing agency offering repurposed for pharma from a team of experts who know the intricacies of pharmaceutical supply chains.
While most marketing companies learn your industry from the outside, TechShu has worked inside the pharma sector for 17+ years, with companies all along the full pharmaceutical value chain. When it comes to our API clients, we already know how you fit into that chain, who your potential buyers are along the way and what it takes to get listed on their approved suppliers' list.
Unlike other marketing companies, we understand every stage of drug development and who buys at each stage - target identification, drug discovery, pre-clinical research, clinical trials, regulatory approval, manufacturing, and commercialization, and we know how to communicate with you at each step.
Discovery and preclinical phases of development necessitate that the research & development and formulation chemists evaluate the quality and availability of APIs for small scale manufacturing. Clinical manufacturing requires the procurement and supply chain managers to assess regulatory status and scale-up potential. Commercial-scale supply is achieved through long-standing sourcing arrangements based on DMF history and GMP audit performance. And each of these buyers is looking for something different and requires a different message to select you.
Regardless of whether you are supplying APIs for early stage discovery, clinical manufacture or commercial formulation - or all three – we understand who your buyers are, what information they use to identify you, and what it takes to select you.
| Development Stage | API Buyer / Stakeholder | What They Need From Your Marketing |
|---|---|---|
| Drug Discovery & Pre-Clinical | R&D scientists, formulation chemists | API availability, purity specs, lab-scale supply, CoA access |
| Clinical Trials (Phase I–III) | Clinical supply chain, procurement | DMF status, GMP certification, clinical batch capability, regulatory filings |
| Regulatory Submission | Regulatory affairs teams | DMF number and filing history, ANDA/NDA support, audit readiness |
| Commercial Manufacturing (CDMO/Formulator) | Procurement, supply chain directors | Commercial-scale GMP capacity, price stability, supply reliability, audit history |
| Generic Drug Launch | Generic formulators, procurement | Certificate of Suitability (CEP), ASMF (earlier EDMF), USP/EP compliance, cost competitiveness |
| Specialty & Patented Formulation | Product development, licensing teams | Custom API development capability, IP considerations, confidentiality |
| International Market Access | Export-focused procurement, distributors | FDA/EMA/PMDA filings, import compliance, documentation quality |
We have an extensive knowledge about the value chain of pharmaceuticals which allows us to develop precise marketing strategies for API manufacturers. Our ability to identify the exact buyer segment in the right buying cycle, message that will meet their requirements, and channels that will reach them at their buying moments distinguishes our results from regular digital marketing efforts.
In case of API manufacturers, it means that we will base our marketing strategies on your molecule portfolio and regulatory approvals, and not on the brand name. We will make your DMF track record known to the buyers, your GMP certification recognized by their AI algorithms, and capability story clear to the purchasing departments.
TechShu’s DMFlow process methodology, developed uniquely for the pharmaceutical supply chain, operates through five distinct stages. The first and foremost aspect of this process lies in the fact that we have extensive pharma knowledge – unlike any other agency.
The initial step involves creating a map of your unique target buyers – formulators, sourcing teams and distributors, the stage at which they are at the drug development lifecycle, the capability positioning of your business, and the markets served. The pharmaceutical value chain understanding of ours comes into play here as we don’t have to learn from scratch what API manufacturers do and who they sell to. Before we pen down even one sentence or plan out one campaign, we already have a good idea of who your perfect client is, what they need right now, and how the whole sourcing decision process works for them.
We conduct an audit of your existing website, content, search presence, and digital footprint against the actual requirements of your target buyers. We audit your positioning compared to competitors and find out the gaps where you’re missing opportunities for visibility and leads. We also examine if the messaging is addressed to the correct audience in the right stage of evaluation – a key component of the API marketing audit that most agencies ignore.
We develop a marketing strategy for API manufacturers which will suit your budget, schedule and business development objectives. We pick up the right keywords, the right structure of the content, the right LinkedIn audience segments and the right approach for event marketing. The decisions are made based on our deep understanding of pharmaceutical buyer’s journey at different stages of development process and not on some trendy practices of digital marketing.
We carry out the strategy: creating content that will rank, implementing LinkedIn campaigns to the target formulator and sourcing accounts, running an event marketing program, and establishing a digital presence that ensures visibility of your capability messaging at all touchpoints of the supplier qualification process. Thanks to our industry knowledge, every piece of content we create speaks directly to the decision-makers.
We provide reporting on leads, buyer accounts, and pipeline activities – not on page views and bounce rates. We can clearly identify the source of each inquiry, analyze the channels that work, and explain the changes we implement. When some channel doesn't produce leads, we optimize it.
Four benefits, which will be tracked based on sourcing inquiries and qualified leads and not website traffic metrics.
Website traffic from formulators, sourcing experts, and procurement managers looking for your specific APIs not any traffic, but qualified traffic of buyers who are actively looking for your products and thus generate sourcing inquiries. Once your pages start ranking for the queries used by buyers, website traffic becomes different.
Appearing in search results when buyers look up your molecules on Google, and in ChatGPT or Perplexity answers when buyers ask for API manufacturers in your product area. We also make your DMF and CEP status easy to find and verify on your own website, so regulatory affairs managers do not have to chase documents. With our answer engine optimization (AEO) service, we work to make your regulatory credentials visible not only in search results but in AI-generated answers as well.
Not just quantity, but quality. Formulators in search of the ideal API sourcing partner; sourcing firms that are working to build a new supply chain; the procurement team of generic drug makers in need of a reliable long-term partner. Leads with context around specific molecules, better qualified before they reach your team.
The cumulative effect of visibility and qualified sourcing leads over 12 months of activity becomes business growth and new supply chain connections, new markets and segments. Six out of India’s top 10 pharma firms partner with TechShu and 70% of our customers stay with us for five or more years as our knowledge of your specific molecule portfolio gets deeper over time.
We track the metrics that move the procurement pipeline – not those that just fill marketing reports.
Years in pharma marketing
Of India’s top 10 pharma brands work with us
Of clients stay with us for 5+ years
Clients, across 20 industries
By crafting content based on molecule names, regulatory filing statuses and specifications- the keywords sourcing agents and procurement teams actually use. A generic "pharma company" landing page will never be ranked for the keywords generating actual inquiries. Molecule-focused pages cantered on the API name, DMF and CEP filing statuses, and GMP will attract your buyer inquiries, including those from ChatGPT and Perplexity buyers searching for suppliers.
Because API buyers research molecules, not brands. A procurement head looking for a paracetamol API would search for "paracetamol API manufacturer India" not "pharmaceutical manufacturing company". A strategy that ignores this difference attracts traffic from the wrong source while your buyers remain undiscovered.
Understanding of the entire value chain of the pharmaceutical industry. This includes knowledge of who exactly purchases APIs throughout the process of drug development and the decision-making process involved. Molecule visibility, making your regulatory filing search engine optimized and getting you in front of the buyer when it is the most relevant time to do so. 17+ years in the pharma industry. Six of the top 10 Indian pharma companies.
Tailoring the visibility of your filings to the markets where you need to reach your target accounts. For example, FDA filings for the US generics market, CEP (EDQM) for the European formulator market, and WHO-GMP certification for international tender markets. Targeting the right people through LinkedIn account-based marketing and B2B lead generation programs for sourcing directors and procurement managers of the right companies.
Month one: a molecule level content audit, a structured data solution for filing DMF/GMP documentation, and a keyword approach based on actual source inquiries. Next, molecule level SEO pages, PPC campaigns, targeting on LinkedIn using ABM on formulator sourcing teams, and a monthly report showing sourcing inquiries and performance of molecules – not page views.
See what is missing in your regulatory filings with a FREE audit of your molecules, filings and certifications.